BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sheng X, Guan Y, Ma Z, Wu J, Liu H, Qiu C, Vitale S, Miao Z, Seasock MJ, Palmer M, Shin MK, Duffin KL, Pullen SS, Edwards TL, Hellwege JN, Hung AM, Li M, Voight BF, Coffman TM, Brown CD, Susztak K. Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments. Nat Genet 2021. [PMID: 34385711 DOI: 10.1038/s41588-021-00909-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu K, Kiryluk K. Mapping GWAS loci to kidney genes and cell types. Kidney Int 2021:S0085-2538(21)01053-X. [PMID: 34774560 DOI: 10.1016/j.kint.2021.10.026] [Reference Citation Analysis]
2 Schreibing F, Kramann R. Mapping the human kidney using single-cell genomics. Nat Rev Nephrol 2022. [PMID: 35301441 DOI: 10.1038/s41581-022-00553-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wopperer FJ, Knaup KX, Stanzick KJ, Schneider K, Jobst-schwan T, Ekici AB, Uebe S, Wenzel A, Schliep S, Schürfeld C, Seitz R, Bernhardt W, Gödel M, Wiesener A, Popp B, Stark KJ, Gröne H, Friedrich B, Weiß M, Basic-jukic N, Schiffer M, Schröppel B, Huettel B, Beck BB, Sayer JA, Ziegler C, Büttner-herold M, Amann K, Heid IM, Reis A, Pasutto F, Wiesener MS. Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases. Kidney International 2022. [DOI: 10.1016/j.kint.2022.04.031] [Reference Citation Analysis]
4 Tomaszewski M, Morris AP, Howson JM, Franceschini N, Eales J, Xu X, Dikalov S, Guzik TJ, Humphreys B, Harrap S, Charchar FJ. Kidney omics in hypertension: from statistical associations to biological mechanisms and clinical applications. Kidney Int 2022:S0085-2538(22)00442-2. [PMID: 35690124 DOI: 10.1016/j.kint.2022.04.045] [Reference Citation Analysis]
5 Semenikhina M, Stefanenko M, Spires DR, Ilatovskaya DV, Palygin O. Nitric-Oxide-Mediated Signaling in Podocyte Pathophysiology. Biomolecules 2022;12:745. [DOI: 10.3390/biom12060745] [Reference Citation Analysis]
6 . Linking genetic variants to kidney disease via the epigenome. Nat Genet 2022. [PMID: 35739388 DOI: 10.1038/s41588-022-01098-9] [Reference Citation Analysis]
7 Rysz J, Franczyk B, Rysz-górzyńska M, Gluba-brzózka A. Are Alterations in DNA Methylation Related to CKD Development? IJMS 2022;23:7108. [DOI: 10.3390/ijms23137108] [Reference Citation Analysis]
8 Liu H, Doke T, Guo D, Sheng X, Ma Z, Park J, Vy HMT, Nadkarni GN, Abedini A, Miao Z, Palmer M, Voight BF, Li H, Brown CD, Ritchie MD, Shu Y, Susztak K. Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease. Nat Genet 2022. [PMID: 35710981 DOI: 10.1038/s41588-022-01097-w] [Reference Citation Analysis]
9 Khan A, Turchin MC, Patki A, Srinivasasainagendra V, Shang N, Nadukuru R, Jones AC, Malolepsza E, Dikilitas O, Kullo IJ, Schaid DJ, Karlson E, Ge T, Meigs JB, Smoller JW, Lange C, Crosslin DR, Jarvik GP, Bhatraju PK, Hellwege JN, Chandler P, Torvik LR, Fedotov A, Liu C, Kachulis C, Lennon N, Abul-Husn NS, Cho JH, Ionita-Laza I, Gharavi AG, Chung WK, Hripcsak G, Weng C, Nadkarni G, Irvin MR, Tiwari HK, Kenny EE, Limdi NA, Kiryluk K. Genome-wide polygenic score to predict chronic kidney disease across ancestries. Nat Med 2022. [PMID: 35710995 DOI: 10.1038/s41591-022-01869-1] [Reference Citation Analysis]
10 Schlosser P, Tin A, Matias-Garcia PR, Thio CHL, Joehanes R, Liu H, Weihs A, Yu Z, Hoppmann A, Grundner-Culemann F, Min JL, Adeyemo AA, Agyemang C, Ärnlöv J, Aziz NA, Baccarelli A, Bochud M, Brenner H, Breteler MMB, Carmeli C, Chaker L, Chambers JC, Cole SA, Coresh J, Corre T, Correa A, Cox SR, de Klein N, Delgado GE, Domingo-Relloso A, Eckardt KU, Ekici AB, Endlich K, Evans KL, Floyd JS, Fornage M, Franke L, Fraszczyk E, Gao X, Gào X, Ghanbari M, Ghasemi S, Gieger C, Greenland P, Grove ML, Harris SE, Hemani G, Henneman P, Herder C, Horvath S, Hou L, Hurme MA, Hwang SJ, Jarvelin MR, Kardia SLR, Kasela S, Kleber ME, Koenig W, Kooner JS, Kramer H, Kronenberg F, Kühnel B, Lehtimäki T, Lind L, Liu D, Liu Y, Lloyd-Jones DM, Lohman K, Lorkowski S, Lu AT, Marioni RE, März W, McCartney DL, Meeks KAC, Milani L, Mishra PP, Nauck M, Navas-Acien A, Nowak C, Peters A, Prokisch H, Psaty BM, Raitakari OT, Ratliff SM, Reiner AP, Rosas SE, Schöttker B, Schwartz J, Sedaghat S, Smith JA, Sotoodehnia N, Stocker HR, Stringhini S, Sundström J, Swenson BR, Tellez-Plaza M, van Meurs JBJ, van Vliet-Ostaptchouk JV, Venema A, Verweij N, Walker RM, Wielscher M, Winkelmann J, Wolffenbuttel BHR, Zhao W, Zheng Y, Loh M, Snieder H, Levy D, Waldenberger M, Susztak K, Köttgen A, Teumer A; Estonian Biobank Research Team., Genetics of DNA Methylation Consortium. Meta-analyses identify DNA methylation associated with kidney function and damage. Nat Commun 2021;12:7174. [PMID: 34887417 DOI: 10.1038/s41467-021-27234-3] [Reference Citation Analysis]
11 Guan Y, Liang X, Ma Z, Hu H, Liu H, Miao Z, Linkermann A, Hellwege JN, Voight BF, Susztak K. A single genetic locus controls both expression of DPEP1/CHMP1A and kidney disease development via ferroptosis. Nat Commun 2021;12:5078. [PMID: 34426578 DOI: 10.1038/s41467-021-25377-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wilson PC, Humphreys BD. Understanding How Genetic Background Affects Kidney Function at the Single-Cell Level. Am J Kidney Dis 2021:S0272-6386(21)01011-8. [PMID: 34871702 DOI: 10.1053/j.ajkd.2021.11.002] [Reference Citation Analysis]
13 Doke T, Huang S, Qiu C, Sheng X, Seasock M, Liu H, Ma Z, Palmer M, Susztak K. Genome-wide association studies identify the role of caspase-9 in kidney disease. Sci Adv 2021;7:eabi8051. [PMID: 34739325 DOI: 10.1126/sciadv.abi8051] [Reference Citation Analysis]
14 Kondratyev NV, Alfimova MV, Golov AK, Golimbet VE. Bench Research Informed by GWAS Results. Cells 2021;10:3184. [PMID: 34831407 DOI: 10.3390/cells10113184] [Reference Citation Analysis]